Cellectar Biosciences, Inc. (CLRB) SEC Filing 8-K Material Event for the period ending Wednesday, March 6, 2019

SEC Filings

Cellectar Biosciences, Inc.

CIK: 1279704 Ticker: CLRB

View differences made from one to another to evaluate Cellectar Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cellectar Biosciences, Inc..


Assess how Cellectar Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cellectar Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: CLRB
CIK: 1279704
Form Type: 8-K Corporate News
Accession Number: 0001144204-19-012994
Submitted to the SEC: Fri Mar 08 2019 4:03:15 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: